The COLBOS mutation was linked to stronger activation of the canonical reelin target Dab1, and this signaling pathway was shown to directly lead to reduction in tau phosphorylation and amelioration of the phenotype in a mouse model of tauopathy [197]. This evidence concerns the gene MAPT and tauopathy.